4//SEC Filing
Stankovic Srdjan R. 4
Accession 0001209191-22-058391
CIK 0001070494other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:34 PM ET
Size
9.3 KB
Accession
0001209191-22-058391
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2022-11-19+6,250→ 63,081 total - Sale
Common Stock
2022-11-21$15.07/sh−1,847$27,834→ 61,234 total - Exercise/Conversion
Restricted Stock Units
2022-11-21−6,250→ 0 total→ Common Stock (6,250 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The restricted stock units vest in four equal annual installments beginning November 19, 2019.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001432545
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:34 PM ET
- Size
- 9.3 KB